EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 59 filers reported holding EDGEWISE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,469,918 | -26.1% | 14,567,176 | 0.0% | 1.77% | -13.3% |
| Q2 2023 | $112,895,614 | +16.2% | 14,567,176 | 0.0% | 2.05% | +7.3% |
| Q1 2023 | $97,163,064 | -25.4% | 14,567,176 | 0.0% | 1.91% | -23.4% |
| Q4 2022 | $130,230,553 | -9.1% | 14,567,176 | 0.0% | 2.49% | -6.4% |
| Q3 2022 | $143,341,000 | +27.9% | 14,567,176 | +3.4% | 2.66% | +31.0% |
| Q2 2022 | $112,098,000 | -17.1% | 14,082,680 | +1.0% | 2.03% | -7.4% |
| Q1 2022 | $135,263,000 | -36.5% | 13,944,680 | 0.0% | 2.19% | -19.9% |
| Q4 2021 | $213,075,000 | -8.0% | 13,944,680 | 0.0% | 2.74% | +7.7% |
| Q3 2021 | $231,482,000 | -22.2% | 13,944,680 | 0.0% | 2.54% | -15.4% |
| Q2 2021 | $297,440,000 | -34.4% | 13,944,680 | 0.0% | 3.01% | -29.0% |
| Q1 2021 | $453,202,000 | – | 13,944,680 | – | 4.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |